Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/hansa-biopharma-increase-in-number-of-shares-and-votes-302135462.html
https://www.prnewswire.com/news-releases/hansa-biopharma-interim-report-january-march-2024-302120655.html
https://www.prnewswire.com/news-releases/hansa-biopharma-expects-strong-first-quarter-2024-sales-performance-302105212.html
https://www.prnewswire.com/news-releases/hansa-biopharma-year-end-report-january-december-2023-302051738.html
https://www.prnewswire.com/news-releases/hansa-biopharma-provides-update-on-business-and-key-financials-ahead-of-the-jp-morgan-healthcare-conference-302027692.html
https://www.prnewswire.com/news-releases/imlifidase-met-primary-endpoint-in-16-hmedides-12-phase-2-trial-in-patients-with-amr-following-kidney-transplantation-302016091.html
https://www.prnewswire.com/news-releases/hansa-biopharma-nomination-committee-formed-302013592.html
https://www.prnewswire.com/news-releases/imlifidase-demonstrated-positive-safety-tolerability-and-early-efficacy-outcomes-in-15-hmedides-09-phase-2-trial-in-guillain-barre-syndrome-gbs-302008430.html
https://www.prnewswire.com/news-releases/hansa-biopharma-plans-restructuring-to-strengthen-long-term-competitiveness-and-advance-key-deliverables-302005996.html
https://www.prnewswire.com/news-releases/hansa-biopharma-interim-report-january-september-2023-301968390.html